These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8676424)

  • 1. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection.
    Hultman CS; Brinson GM; Siltharm S; deSerres S; Cairns BA; Peterson HD; Meyer AA
    J Trauma; 1996 Jul; 41(1):51-8; discussion 58-60. PubMed ID: 8676424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of cultured keratinocyte allografts deficient in major histocompatibility complex antigens.
    Hultman CS; Hunt JP; Yamamoto H; Giannopoulos A; deSerres S; Frelinger JA; Meyer AA
    J Trauma; 1998 Jul; 45(1):25-33; discussion 33-4. PubMed ID: 9680007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response.
    Cairns BA; deSerres S; Matsui M; Frelinger JA; Meyer AA
    Transplantation; 1994 Jul; 58(1):67-72. PubMed ID: 8036710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenogeneic mouse fibroblasts persist in human cultured epidermal grafts: a possible mechanism of graft loss.
    Cairns BA; deSerres S; Brady LA; Hultman CS; Meyer AA
    J Trauma; 1995 Jul; 39(1):75-9; discussion 79-80. PubMed ID: 7636913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival of cultured keratinocyte allografts in the nonimmunosuppressed mouse.
    Hammond EJ; Ng RL; Stanley MA; Munro AJ
    Transplantation; 1987 Jul; 44(1):106-12. PubMed ID: 3299909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
    Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
    J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts.
    Hultman CS; Cairns BA; deSerres S; Frelinger JA; Meyer AA
    Transplantation; 1995 Sep; 60(6):584-9. PubMed ID: 7570955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of antigenicity and immunogenicity of neonatal epidermal allografts in the mouse.
    Demidem A; Chiller JM; Kanagawa O
    Transplantation; 1990 May; 49(5):966-71. PubMed ID: 2336712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection, after a slightly prolonged survival time, of Langerhans cell-free allogeneic cultured epidermis used for wound coverage in humans.
    Auböck J; Irschick E; Romani N; Kompatscher P; Höpfl R; Herold M; Schuler G; Bauer M; Huber C; Fritsch P
    Transplantation; 1988 Apr; 45(4):730-7. PubMed ID: 3258682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1995 Moyer Award. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitization.
    Hultman CS; Cairns BA; Yamamoto H; deSerres S; Frelinger JA; Meyer AA
    J Burn Care Rehabil; 1995; 16(6):573-80. PubMed ID: 8582933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that epidermal alloantigen Epa-1 is an immunogen for murine heart as well as skin allograft rejection.
    Steinmuller D; Wakely E; Landas SK
    Transplantation; 1991 Feb; 51(2):459-63. PubMed ID: 1994543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
    Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
    Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of allogeneic epidermis in murine graft rejection.
    Lerner-Tung MB; Hull BE
    J Burn Care Rehabil; 1989; 10(2):151-5. PubMed ID: 2651451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured keratinocyte grafts are recognized, but not rejected by CD8+ T cells in vivo.
    Tinois E; Cobbold S; Faure M; Yeoman H; Stanley M
    Eur J Immunol; 1989 Jun; 19(6):1031-5. PubMed ID: 2473908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection of cultured keratinocyte allografts in presensitized mice.
    Kawai K; Ikarashi Y; Tomiyama K; Matsumoto Y; Fujiwara M
    Transplantation; 1993 Aug; 56(2):265-9. PubMed ID: 8356578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune tolerance of tissue-engineered skin produced with allogeneic or xenogeneic fibroblasts and syngeneic keratinocytes grafted on mice.
    Goyer B; Larouche D; Kim DH; Veillette N; Pruneau V; Bernier V; Auger FA; Germain L
    Acta Biomater; 2019 May; 90():192-204. PubMed ID: 30953802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
    Erdag G; Morgan JR
    Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured keratinocyte allografts fail to induce sensitization in vivo.
    Cairns BA; deSerres S; Kilpatrick K; Frelinger JA; Meyer AA
    Surgery; 1993 Aug; 114(2):416-22. PubMed ID: 8342143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro production and transplantation of immunologically active skin equivalents.
    Rouabhia M
    Lab Invest; 1996 Oct; 75(4):503-17. PubMed ID: 8874382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.